Investment Stage

Focus Areas

About Investor

Michael Fenn serves as a Venture Partner at Iaso Ventures, focusing on investments in pharmaceuticals, consumer health, biotech, health IT, wellness & fitness, therapeutics, digital health, and health & hospital services sectors. He typically invests at the seed and Series A stages with an investment range of $100K - $5.0M and a sweet spot of $1.5M. Fenn is a seasoned biotech operator and investor with experience on both sides of the table, currently serving as Head of External Innovation at Dewpoint Therapeutics and as an Innovation Fellow at Harvard Innovation Labs. He holds a Ph.D. in Biomedical Engineering, M.S. in Materials Science and Engineering, and B.S. in Chemistry/Biochemistry from the University of Florida.